PubMed

Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.

Treon SP, Soumerai JD, Branagan AR, Hunter ZR, Patterson CJ, Ioakimidis L, Chu L, Musto P, Baron AD, Nunnink JC, Kash JJ, Terjanian TO, Hyman PM, Nawfel EL, Sharon DJ, Munshi NC, Anderson KC.

Clin Cancer Res. 2009 Jan 1;15(1):355-60.PMID: 19118065 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer.

Hussain A, DiPaola RS, Baron AD, Higano CS, Tchekmedyian NS, Johri AR.

Ann Oncol. 2009 Mar;20(3):492-7. Epub 2008 Dec 15.PMID: 19087985 [PubMed - indexed for MEDLINE]Related articles

The novel antioxidant, AC3056 (2,6-di-t-butyl-4-((dimethyl-4-methoxyphenylsilyl)methyloxy)phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men.

Angulo J, Peiró C, Cuevas P, Gabancho S, Fernández A, González-Corrochano R, La Fuente JM, Baron AD, Chen KS, de Tejada IS.

J Sex Med. 2009 Feb;6(2):373-87. Epub 2008 Nov 18.PMID: 19040617 [PubMed - indexed for MEDLINE]Related articles

Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.

Lteif AA, Fulford AD, Considine RV, Gelfand I, Baron AD, Mather KJ.

Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1510-7. Epub 2008 Oct 28.PMID: 18957616 [PubMed - indexed for MEDLINE]Related articles

Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.

Trevaskis JL, Coffey T, Cole R, Lei C, Wittmer C, Walsh B, Weyer C, Koda J, Baron AD, Parkes DG, Roth JD.

Endocrinology. 2008 Nov;149(11):5679-87. Epub 2008 Jul 31.PMID: 18669592 [PubMed - indexed for MEDLINE]Related articlesFree article

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.

Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD.

Proc Natl Acad Sci U S A. 2008 May 20;105(20):7257-62. Epub 2008 May 5.PMID: 18458326 [PubMed - indexed for MEDLINE]Related articlesFree article

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.

Burstein HJ, Keshaviah A, Baron AD, Hart RD, Lambert-Falls R, Marcom PK, Gelman R, Winer EP.

Cancer. 2007 Sep 1;110(5):965-72.PMID: 17614302 [PubMed - indexed for MEDLINE]Related articlesFree article

Endothelin limits insulin action in obese/insulin-resistant humans.

Lteif A, Vaishnava P, Baron AD, Mather KJ.

Diabetes. 2007 Mar;56(3):728-34.PMID: 17327443 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.

Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM.

Endocrinology. 2006 Dec;147(12):5855-64. Epub 2006 Aug 24.PMID: 16935845 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.

Ross HJ, Hart LL, Swanson PM, Rarick MU, Figlin RA, Jacobs AD, McCune DE, Rosenberg AH, Baron AD, Grove LE, Thorn MD, Miller DM, Drachman JG, Rudin CM.

Lung Cancer. 2006 Oct;54(1):69-77. Epub 2006 Aug 28.PMID: 16934909 [PubMed - indexed for MEDLINE]Related articles

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.

Carpenter T, Trautmann ME, Baron AD.

N Engl J Med. 2005 Nov 17;353(20):2192-4; author reply 2192-4. No abstract available. PMID: 16291992 [PubMed - indexed for MEDLINE]Related articles

Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes.

Taylor K, Kim D, Nielsen LL, Aisporna M, Baron AD, Fineman MS.

Horm Metab Res. 2005 Oct;37(10):627-32.PMID: 16278786 [PubMed - indexed for MEDLINE]Related articles

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD.

Diabetes Care. 2005 May;28(5):1092-100.PMID: 15855572 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD.

Diabetes Care. 2005 May;28(5):1083-91.PMID: 15855571 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.

Brame LA, Considine RV, Yamauchi M, Baron AD, Mather KJ.

Obes Res. 2005 Mar;13(3):582-8.PMID: 15833944 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.

Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, Baron AD.

Am J Health Syst Pharm. 2005 Jan 15;62(2):173-81.PMID: 15700891 [PubMed - indexed for MEDLINE]Related articles

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.

Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG, Young AA.

Endocrinology. 2005 Apr;146(4):2069-76. Epub 2004 Dec 23.PMID: 15618356 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD; Exenatide-113 Clinical Study Group.

Diabetes Care. 2004 Nov;27(11):2628-35.PMID: 15504997 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.

Fineman MS, Shen LZ, Taylor K, Kim DD, Baron AD.

Diabetes Metab Res Rev. 2004 Sep-Oct;20(5):411-7.PMID: 15343588 [PubMed - indexed for MEDLINE]Related articles

Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.

Mather KJ, Lteif A, Steinberg HO, Baron AD.

Diabetes. 2004 Aug;53(8):2060-6.PMID: 15277386 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.

Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD.

Diabetes Care. 2003 Aug;26(8):2370-7.PMID: 12882864 [PubMed - indexed for MEDLINE]Related articlesFree article

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD.

J Clin Endocrinol Metab. 2003 Jul;88(7):3082-9.PMID: 12843147 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes.

Nielsen LL, Baron AD.

Curr Opin Investig Drugs. 2003 Apr;4(4):401-5.PMID: 12808878 [PubMed - indexed for MEDLINE]Related articles

Weight loss and endothelial function in obesity.

Mather KJ, Steinberg HO, Baron AD.

Diabetes Care. 2003 Jun;26(6):1927-8. No abstract available. PMID: 12766136 [PubMed - indexed for MEDLINE]Related articlesFree article

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.

Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.

J Clin Endocrinol Metab. 2003 Feb;88(2):576-80.PMID: 12574183 [PubMed - indexed for MEDLINE]Related articlesFree article

Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.

Baron AD, Kim D, Weyer C.

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Apr;2(1):63-82. Review.PMID: 12477297 [PubMed - indexed for MEDLINE]Related articles

Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.

Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD.

Diabetes. 2002 Dec;51(12):3517-23.PMID: 12453909 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular function, insulin resistance and fatty acids.

Steinberg HO, Baron AD.

Diabetologia. 2002 May;45(5):623-34. Epub 2002 Apr 4. Review.PMID: 12107742 [PubMed - indexed for MEDLINE]Related articles

Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.

Mather KJ, Paradisi G, Leaming R, Hook G, Steinberg HO, Fineberg N, Hanley R, Baron AD.

Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):118-26.PMID: 11994903 [PubMed - indexed for MEDLINE]Related articles

[Insulin mitigates the effect of free fatty acid to cause endothelial dysfunction in rat aortic rings]

Yu Y, Zhu J, Wu Y, Baron AD.

Zhonghua Yi Xue Za Zhi. 2002 Mar 25;82(6):422-5. Chinese. PMID: 11953213 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance and vascular function.

Baron AD.

J Diabetes Complications. 2002 Jan-Feb;16(1):92-102. Review.PMID: 11872375 [PubMed - indexed for MEDLINE]Related articles

Repeatability characteristics of simple indices of insulin resistance: implications for research applications.

Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, Quon MJ, Baron AD.

J Clin Endocrinol Metab. 2001 Nov;86(11):5457-64.PMID: 11701722 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired glucose tolerance as a disease.

Baron AD.

Am J Cardiol. 2001 Sep 20;88(6A):16H-9H. Review.PMID: 11576521 [PubMed - indexed for MEDLINE]Related articles

Response to Bell: industry perspective.

Baron AD.

Diabetes Care. 2001 Apr;24(4):769-70. No abstract available. PMID: 11315845 [PubMed - indexed for MEDLINE]Related articlesFree article

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

Polycystic ovary syndrome is associated with endothelial dysfunction.

Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK, Baron AD.

Circulation. 2001 Mar 13;103(10):1410-5.PMID: 11245645 [PubMed - indexed for MEDLINE]Related articlesFree article

Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.

Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD.

Diabetes. 2000 Jul;49(7):1231-8.PMID: 10909983 [PubMed - indexed for MEDLINE]Related articlesFree article

Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment.

Baron AD, Tarshoby M, Hook G, Lazaridis EN, Cronin J, Johnson A, Steinberg HO.

Diabetes. 2000 May;49(5):768-74.PMID: 10905485 [PubMed - indexed for MEDLINE]Related articlesFree article

Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD.

Diabetes. 2000 May;49(5):684-7.PMID: 10905473 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ.

J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10.PMID: 10902785 [PubMed - indexed for MEDLINE]Related articlesFree article

Type II diabetes abrogates sex differences in endothelial function in premenopausal women.

Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD.

Circulation. 2000 May 2;101(17):2040-6.PMID: 10790344 [PubMed - indexed for MEDLINE]Related articlesFree article

Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.

Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, Johnson A, Cronin J, Steinberg HO, Baron AD.

Diabetes Care. 1999 Aug;22(8):1310-7.PMID: 10480776 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse.

Shen HQ, Zhu JS, Baron AD.

Metabolism. 1999 Aug;48(8):965-70.PMID: 10459559 [PubMed - indexed for MEDLINE]Related articles

Vascular reactivity.

Baron AD.

Am J Cardiol. 1999 Jul 8;84(1A):25J-27J. Review.PMID: 10418855 [PubMed - indexed for MEDLINE]Related articles

Impaired glucose tolerance. Why is it not a disease?

Perry RC, Baron AD.

Diabetes Care. 1999 Jun;22(6):883-5. Review. No abstract available. PMID: 10372235 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle.

Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, Kahn BB.

Diabetes. 1999 Feb;48(2):310-20.PMID: 10334307 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-mediated vasodilation: why one's physiology could be the other's pharmacology.

Steinberg HO, Baron AD.

Diabetologia. 1999 Apr;42(4):493-5. No abstract available. PMID: 10230655 [PubMed - indexed for MEDLINE]Related articles

Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.

Shankar R, Zhu JS, Ladd B, Henry D, Shen HQ, Baron AD.

J Clin Invest. 1998 Oct 1;102(7):1403-12.PMID: 9769333 [PubMed - indexed for MEDLINE]Related articlesFree article

Postprandial hyperglycaemia and alpha-glucosidase inhibitors.

Baron AD.

Diabetes Res Clin Pract. 1998 Jul;40 Suppl:S51-5. Review.PMID: 9740503 [PubMed - indexed for MEDLINE]Related articles

Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.

Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD.

J Clin Invest. 1998 Jun 1;101(11):2377-86.PMID: 9616209 [PubMed - indexed for MEDLINE]Related articlesFree article